An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils

Conditions:   Asthma;   Elevated Blood Eosinophils
Interventions:   Drug: Reslizumab;   Drug: Placebo
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified July 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.